MedTrace Logo

Antioxidant Supplementation in Patients With Kashin-Beck Disease

NCT00376025 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2008-02-22

No results posted yet for this study

Summary

The purpose of this study is to determine whether antioxidant supplementation can have a positive health effect on patients suffering from Kashin-Beck disease.

Conditions

  • Kashin-Beck Disease

Interventions

DIETARY_SUPPLEMENT

Biological Antioxidant Supplementation

Supplementation of affected population with the Phytochemical antioxidant, Garcinia Mangostata in addition to sodium selenate.

Sponsors & Collaborators

  • University of Houston - Victoria

    collaborator OTHER

  • Innovative Humanitarian Solutions

    lead OTHER

Principal Investigators

  • Richard Gunasekera, Ph.D. · University of Houston - Victoria

  • Jeff C Cokenour, B.S. · Innovative Humanitarian Solutions

  • Minh Han, M.D. · Innovative Humanitarian Solutions

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
9 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2009-01-31
Completion
2009-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00376025 on ClinicalTrials.gov